01 1Hebei Jiheng Pharmaceutical Co., Ltd.
02 1Shandong Xinhua Pharmaceutical Co., Ltd.
01 1METAMIZOLE SODIUM MONOHYDRATE
02 1metamizole sodium
01 2China
NDC Package Code : 81919-005
Start Marketing Date : 2020-10-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58624-0707
Start Marketing Date : 2024-03-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
56
PharmaCompass offers a list of Metamizole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Metamizole manufacturer or Metamizole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Metamizole manufacturer or Metamizole supplier.
PharmaCompass also assists you with knowing the Metamizole API Price utilized in the formulation of products. Metamizole API Price is not always fixed or binding as the Metamizole Price is obtained through a variety of data sources. The Metamizole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate, including repackagers and relabelers. The FDA regulates Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate supplier is an individual or a company that provides Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate active pharmaceutical ingredient (API) or Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate finished formulations upon request. The Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate suppliers may include Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate suppliers with NDC on PharmaCompass.
We have 2 companies offering Sodium 1-phenyl-2,3-dimethyl-5-pyrazolone-4-methylamino methanesulfonate
Get in contact with the supplier of your choice:
